US experts are curious and skeptical about a new Alzheimer's disease (AD) drug (GV-971; oligomannate; Shanghai Green Valley Pharmaceuticals, China) that was conditionally approved earlier this month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback